News
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
The World Health Organisation (WHO) has for the first time recommended the use of injectable lenacapavir (LEN) as a ...
Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...
The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...
5d
CultureMap Austin on MSNCity of Austin's HIV/AIDS group to hold town hall for feedbackAustinites impacted by HIV/AIDS have an opportunity to make their needs known at a town hall held by the Austin Area HIV ...
2d
NewsDay on MSNZim reaffirms commitment to HIV responseHEALTH and Child Care minister Douglas Mombeshora has reaffirmed the country’s commitment to advancing HIV research, ...
Spread This NewsBy Anna Chibamu Permanant Secretary in the Ministry of Health and Child Care Dr Aspect Maunganidze says the ...
6d
ThePrint on MSNUNAIDS 2025 report warns of funding gaps in fight against HIV as India battles stigma, discriminationGlobal AIDS Update shows that 30% of surveyed Indians aged 15-49 reported facing stigma. Domestic violence, little autonomy over healthcare among key concerns of women with HIV.
: WHO-approved HIV preventive drug Lenacapavir to be rolled out next year to allow for changes in existing guidelines and ...
Zimbabwe has earned widespread international praise for its achievements in the fight against HIV, with the latest UNAIDS Global AIDS Update 2025 placing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results